MedTrace Logo

Impact of Free Mobility on FDG Uptake in PET Scans

NCT06799819 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2025-05-18

No results posted yet for this study

Summary

Positron Emission Tomography (PET) is a rather long examination (around 2 hours), involving an injection of 18F-Fluorodeoxyglucose (FDG), which requires the patient to rest for 1 hour between the injection and the start of imaging. Some hospitals allow the patient to sit, read or use the telephone, but none allow the patient to move freely after injection, hence the interest of this work. The aim of this study is to demonstrate that free mobilization of the patient following 18F-FDG injection does not result in any significant difference in imaging quality (particularly muscular fixations), and therefore a medical interpretation identical to that of a patient who remains at rest.

Conditions

  • Neoplasms
  • Whole Body Imaging

Interventions

BEHAVIORAL

Mobility group

Free mobility between FDG injection and scanning (without exiting the Nuclear Medicine Department)

Sponsors & Collaborators

  • Centre Hospitalier Régional d'Orléans

    lead OTHER

Principal Investigators

  • Adeline FRAT · CHU Orléans

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06799819 on ClinicalTrials.gov